Aprepitant/5HT-3 antagonist (EMEND) for the prevention of chemoradiation-induced nausea and vomiting (CRINV) in patients receiving gemcitabine/ 5-FU–based chemoradiation and concurrent upper abdominal radiation for pancreatic cancer
Year: 2009
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: A. W. Blackstock, M. Aklilu, J. Lovato, L. Degrass, J. Sommer, R. Howerton, G. Mishra, E. Levine, R. McQuellon
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1948324088